Status:
COMPLETED
Late-onset Sepsis and Development
Lead Sponsor:
Nigde Omer Halisdemir University
Conditions:
Sepsis Newborn
Motor Development
Eligibility:
All Genders
10-18 years
Brief Summary
Neonatal sepsis is classified as early-onset and late-onset sepsis. Early-onset sepsis occurs within the first 72 hours after birth and is associated with a mortality rate of 10-15%. Late-onset sepsis...
Detailed Description
Neonatal sepsis is a common condition that triggers both pro- and anti-inflammatory responses in the organism, affects various tissues, and alters enzymatic activities. Immaturity of the immune system...
Eligibility Criteria
Inclusion
- Term infants with a history of late-onset sepsis
- Post-term infants between 10-18 months
Exclusion
- History of early neonatal sepsis,
- Preterm infants,
- Those with congenital infection or proven genetic alterations,
- Infants diagnosed with metabolic, neurological and genetic diseases,
- Children whose parents do not volunteer for the study
Key Trial Info
Start Date :
March 19 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2025
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT06884969
Start Date
March 19 2025
End Date
May 15 2025
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nigde Omer Halisdemir University
Niğde, Turkey (Türkiye)